Compare Eli Lilly And Co (LLY) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? Eli Lilly And Co trades at $1,176.52 (market cap $1.04T), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $25.9 (market cap $2.03B). The key difference: Eli Lilly And Co is far larger — about 512.3× Direxion Daily 20 Year Treasury Bull 3X Shares's market cap, and Eli Lilly And Co pays a 0.59% dividend while Direxion Daily 20 Year Treasury Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Direxion Daily 20 Year Treasury Bull 3X Shares for 28 Days on average.
| LLY | TMF | |
|---|---|---|
Market Cap | $1.04T | $2.03B |
Volume | 3,064,878 | 12,241,664 |
Sector | Health | Fixed Income |
52-Week High | $1.28K | $44.14 |
52-Week Low | $799.57 | $25.19 |
Typical Hold Time | 93 Days | 28 Days |
Enterprise Value | $1.09T | — |
Dividend Yield | 0.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.
TMF, the Direxion Daily 20+ Year Treasury Bull 3X ETF, trades at $25.93, up 2.75% with elevated volume. Technical indicators show a bearish trend from moving averages, though oscillators are neutral. The ETF saw increased trading interest recently, with support at $25 and resistance at $26.
As a leveraged ETF tracking long-term Treasuries, TMF's outlook hinges on interest rate trends. Opportunities exist if rates fall, but risks include rate hikes and volatility decay. Investors should monitor Fed policy for directional cues amid current bearish technicals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
